T
Tomonori Yamauchi
Researcher at Chiba University
Publications - 14
Citations - 478
Tomonori Yamauchi is an academic researcher from Chiba University. The author has contributed to research in topics: Low back pain & Signal transduction. The author has an hindex of 9, co-authored 13 publications receiving 356 citations. Previous affiliations of Tomonori Yamauchi include University of California, San Diego.
Papers
More filters
Journal ArticleDOI
Perioperative Complications in 155 Patients Who Underwent Oblique Lateral Interbody Fusion Surgery: Perspectives and Indications From a Retrospective, Multicenter Survey.
Koki Abe,Sumihisa Orita,Chikato Mannoji,Hiroyuki Motegi,Masaaki Aramomi,Tetsuhiro Ishikawa,Toshiaki Kotani,Tsutomu Akazawa,Tatsuo Morinaga,Takayuki Fujiyoshi,Fumio Hasue,Masatsune Yamagata,Mitsuhiro Hashimoto,Tomonori Yamauchi,Yawara Eguchi,Munetaka Suzuki,Eiji Hanaoka,Kazuhide Inage,Jun Sato,Kazuki Fujimoto,Yasuhiro Shiga,Hirohito Kanamoto,Kazuyo Yamauchi,Junichi Nakamura,Takane Suzuki,Richard A. Hynes,Yasuchika Aoki,Kazuhisa Takahashi,Seiji Ohtori +28 more
TL;DR: The analysis based on surgeon experience indicated that the OLIF procedure could be performed without increasing incidence of complications, under the guidance of experienced supervisors.
Journal ArticleDOI
Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial
Hiroshi Takahashi,Masashi Yamazaki,Akihiko Okawa,Tsuyoshi Sakuma,Kei Kato,Mitsuhiro Hashimoto,Koichi Hayashi,Takeo Furuya,Takayuki Fujiyoshi,Junko Kawabe,Tomonori Yamauchi,Chikato Mannoji,Tomohiro Miyashita,Ryo Kadota,Masayuki Hashimoto,Yasuo Ito,Kazuhisa Takahashi,Masao Koda +17 more
TL;DR: Results indicate that intravenous administration of G-CSF (10 μg/kg/day) for 5 days is essentially safe, and suggest that some neurological recovery may occur in most patients, suggesting that G- CSF administration could be therapeutic for patients with acute SCI.
Journal ArticleDOI
Efficacy and reliability of highly functional open source DICOM software (OsiriX) in spine surgery
Tomonori Yamauchi,Masashi Yamazaki,Akihiko Okawa,Takeo Furuya,Koichi Hayashi,Tsuyoshi Sakuma,Hiroshi Takahashi,Noriyuki Yanagawa,Masao Koda +8 more
TL;DR: OsiriX has approximately equivalent values to commercial software and provides reliable preoperative 3D information for the surgical field and any clinician, can obtain information using OsiriX at any time.
Journal ArticleDOI
ISSLS PRIZE IN CLINICAL SCIENCE 2019: clinical importance of trunk muscle mass for low back pain, spinal balance, and quality of life—a multicenter cross-sectional study
Yusuke Hori,Masatoshi Hoshino,Kazuhide Inage,Masayuki Miyagi,Shinji Takahashi,Shoichiro Ohyama,Akinobu Suzuki,Tadao Tsujio,Hidetomi Terai,Sho Dohzono,Ryuichi Sasaoka,Hiromitsu Toyoda,Minori Kato,Akira Matsumura,Takashi Namikawa,Masahiko Seki,Kentaro Yamada,Hasibullah Habibi,Hamidullah Salimi,Masaomi Yamashita,Tomonori Yamauchi,Takeo Furuya,Sumihisa Orita,Satoshi Maki,Yasuhiro Shiga,Masahiro Inoue,Gen Inoue,Hisako Fujimaki,Kosuke Murata,Ayumu Kawakubo,Daijiro Kabata,Ayumi Shintani,Seiji Ohtori,Masashi Takaso,Hiroaki Nakamura +34 more
TL;DR: Trunk muscle mass may assume an important role to elucidate and treat lumbar spinal dysfunction and spinal imbalance and was significantly correlated with the ODI, VAS score, SVA, and EQ5D score.
Journal ArticleDOI
The Unfolded Protein Response Is a Major Mechanism by Which LRP1 Regulates Schwann Cell Survival after Injury
Elisabetta Mantuano,Kenneth Henry,Tomonori Yamauchi,Nobuhiko Hiramatsu,Kazuyo Yamauchi,Sumihisa Orita,Kazuhisa Takahashi,Jonathan H. Lin,Steven L. Gonias,W. Marie Campana +9 more
TL;DR: LRP1 functions as a potent activator of PI3K in SCs and, by this mechanism, limits SC apoptosis resulting from increased CHOP expression in nerve injury, which supports a model in which UPR-activated signaling pathways represent a major challenge to SC survival in nerve injuries.